Uma M. Reddy, professor of obstetrics and gynecology, is among a select group of leaders in medicine and health elected to the National Academy of Medicine in 2024.

The First Lady of Greece, Mareva Grabowski-Mitsotakis, visited the laboratory of Elisa Konofagou, which is developing a new therapy for children with brain cancer.

Physicians, researchers, students, and staff at Columbia University Irving Medical Center met with legislators on Capitol Hill to advocate for medical research.

Misconception Being LGBT is by definition a psychological problem. Reality For the past forty years, we have recognized that homosexual and bisexual orientations are normal variants of human sexuality ...

With each new season comes renewed optimism and energy, and we very much look forward to the incredible work that will take place this fall across our pillars of teaching, research, and patient care.

Columbia University today announced the establishment of the Stavros Niarchos Foundation (SNF) Center for Precision Psychiatry & Mental Health at Columbia University. The center will catalyze the ...

Researchers report that CRISPR-Cas9 gene-editing technology can introduce hundreds of unintended mutations into the genome.

Spontaneous errors in the earliest phase of cell division may explain why so many human embryos fail to develop normally, according to research from Columbia University.

Since most people, not just postmenopausal women, experience a rapid rise in blood sugar after eating refined carbohydrates, the authors suspect that these findings may also hold true in a broader ...

A type of ultraviolet light called far-UVC—which is safe to use around people—kills more than 99.9% of airborne coronaviruses, a new study at Columbia has found.

Diano and her team study things like the physiological mechanisms that regulate how much food we consume, the link between depression and appetite, and how high-fat diets cause brain inflammation. The ...

Based on Columbia research, an experimental drug for a rare type of ALS is being tested in a phase 3 clinical trial after a new study found that the drug lowered levels of a toxic protein.